细胞系鉴定

¥1200
2021-08-12 10:44

苏州鉴达生物科技有限公司

我要认领
苏州鉴达生物科技有限公司
王飞
18112556997 0512-62806339
2791427499@qq.com
产品属性
规格1200/株
产品说明

For further information, please scan the QR code below to follow us

应用于生物医学研究领域的哺乳动物细胞被错误鉴定和交叉污染的问题,一直是普遍存在的一个突出问题。据统计,国外实验室有20%左右的细胞株被错误鉴定和交叉污染,NIH和ATCC近两年都对此发出呼吁,要求研究者对细胞进行鉴定。一些权威杂志在作者投稿时就要求提供细胞株的STR基因型鉴定证明。

近年来,大量研究表明STR基因分型方法是进行细胞交叉污染和性质鉴定的最有效和准确的方法之一,STR基因分型应用于细胞鉴定已被ATCC等机构强烈推荐。

我公司推出了细胞STR鉴定服务并与多家研究机构、细胞中心、生产厂商等建立长期合作关系。现行技术科同时分析多个STR基因座,可以准确的判断交叉污染和细胞类型。微量样本即可满足检测需求,并且可以检测到早期污染。

 1、细胞送样要求:
特别提醒:目前只针对人源细胞进行STR鉴定,非人源细胞暂不受理。
拟进行的细胞鉴定的客户首先应在ATCC等官方网站查询需要鉴定的细胞有没有被ATCC等数据库收录,不详之处可咨询公司在线客服。同时请将以下信息发给我公司在线客服:单位名称(发票抬头)、课题负责人(老板)姓名、电话及电子邮箱。公司将拟好的委托合同发送至客户,负责人在合同上签字后和细胞悬液一起快递至公司。

2、送检细胞:
1×10的五次方以上细胞悬液置于1.5毫升EP管,用封口膜密封,管壁标记清楚细胞的名称(如HepG2),数量较多时可用编号,并附送检清单。随委托合同一起快递至我公司即可(细胞状态与STR检测无关,请放心邮寄)。

3、细胞株邮寄地址:
苏州市工业园区集贤街88号益新大厦303, 王飞 收 电话:18112556997,建议使用顺丰快递。细胞寄出后联系在线客服,告知运单编号,以便查询。

4、细胞株鉴定收费标准:
高等院校及科研机构1200元/株,其他机构或个人:1440元/株。细胞株数量大于50的机构另行议价。

5、检测时限:
正常情况下,收到样本后一个工作日完成检测,并出具正式检测报告。

6、报告形式:
针对细胞株鉴定,本公司将出具英文版报告,可直接用于外文杂志投稿。可联系公司在线客服索取报告模板及样式。

7、标注优惠政策:
如客户在发表的高水平SCI论文(IF>8)中标注细胞株鉴定由我公司完成,我们承诺为客户免费检测两株细胞株。标注格式如下:The cell lines were characterized by Genetic Testing Biotechnology Corporation (Suzhou, China) using short tandem repeat (STR) markers.
8、利用苏州鉴达生物科技细胞株鉴定服务发表的部分高水平(IF>5)论文(截止2021-3-12
[1]. Ren A et al., Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer. Int J Cancer. 2019 Jul 1;145(1):154-163. PMID: 30561001
[2]. Shen Y, Zhang W, Liu J, He J, Cao R, Chen X, Peng X, Xu H, Zhao Q, Zhong J, Ding W, Lei X, Jiang Y, Zu X. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET. Int J Cancer. 2019 Feb 1;144(3):651-664. doi: 10.1002/ijc.31915. Epub 2018 Nov 7.PMID: 30289981
[3]. Xu H, Han H, Song S, Yi N, Qian C, Qiu Y, Zhou W, Hong Y, Zhuang W, Li Z8, Li B, Zhuang W. Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma. Clin Cancer Res. 2019 Jan 4. pii: clincanres.2363.2018. doi: 10.1158/1078-0432.CCR-18-2363. PMID: 30610101 
[4]. Li B, Han H, Song S, Fan G, Xu H, Zhou W, Qiu Y, Qian C, Wang Y, Yuan Z, Gao Y, Zhang Y, Zhuang W. HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with its Natural Antisense Transcript lncHOXC-AS3. Stem Cells. 2018 Oct 23. doi: 10.1002/stem.2925. PMID: 30353595
[5]. Shi J, Song S, Han H, Xu H, Huang M, Qian C, Zhang X, Ouyang L, Hong Y, Zhuang W, Li B. Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma. Mol Pharm. 2018 Sep 4;15(9):4139-4147. doi: 10.1021/acs.molpharmaceut.8b00554. Epub 2018 Aug 9. PMID: 30048594
[6]. Li B, Xu H, Han H, Song S, Zhang X, Ouyang L, Qian C, Hong Y, Qiu Y, Zhou W, Huang M, Zhuang W. Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene. 2018 Oct;37(41):5508-5519. doi: 10.1038/s41388-018-0359-0. Epub 2018 Jun 12. PMID: 29895968
[7]. Yuan Y, Qi G, Shen H, Guo A, Cao F, Zhu Y, Xiao C, Chang W, Zheng S. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31736. PMID: 29987896
[8]. Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018 Jun;68(6):1214-1227. PMID: 29378234
[9]. Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, Sun M, Chen B, Zhao W, Wang L, Wang H, Moran MS, Haffty BG, Yang Q.SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Cell Death Differ. 2018 Jul 9. doi: 10.1038/s41418-018-0158-8. PMID: 29988076
[10]. Du L, Han XG, Tu B, Wang MQ, Qiao H, Zhang SH, Fan QM, Tang TT. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis. Cell Death Dis. 2018 Jun 18;9(7):714. PMID: 29915309
[11]. Zhou P, Qin J, Li Y, Li G, Wang Y, Zhang N, Chen P, Li C. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis. J Exp Clin Cancer Res. 2017 Sep 2;36(1):115. PMID:28865485
[12]. Wang X, Cheng Y, Zhu Y, Li H, Ge W, Wu X, Zhao K, Yuan J, Li Z, Jiang S, Han Z, Jiang Q, Wu Q, Liu T, Zhang C, Yu M, Hu Y. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30852. PMID: 28656647
[13]. Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, Guo F, He Y, Liu Y, Huang Q, Liang H, Li D, He F. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017 Aug 24;8(1):347. doi: 10.1038/s41467-017-00299-9. PMID: 28839186
[14]. Wang C, Li L, Yin Z, Zhang Q, Zhao H, Tao R, Wang S, Hu S, He Y, Wang D, Li C, Zhang S, Xu J, Jiang X, Zhu S, Gao Y. An Indel Polymorphism within pre-miR3131 Confers Risk for Hepatocellular Carcinoma. Carcinogenesis. 2017;38:168-76. PMID:28034876
[15]. Wang X, Yu M, Zhao K, He M, Ge W, Sun Y, Wang Y, Sun H, Hu Y. Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2. Cell Death Dis. 2016;7(12):e2517. PMID:27929537
[16]. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, Wang J, Wang R, She J, Zhang J, Yang J, Liu Y, Liu P. CRB3 downregulation confers breast cancer stem cell traits through TAZ/β-catenin. Oncogenesis. 2017 Apr 24;6(4):e322. PMID:28436991
[17]. Du J, Shang J, Chen F, Zhang Y, Yin N, Xie T, Zhang H, Yu J, Liu F. A CRISPR/Cas9-Based Screening for Non-Homologous End Joining Inhibitors Reveals Ouabain and Penfluridol as Radiosensitizers. Mol Cancer Ther. 2018 Feb;17(2):419-431. PMID: 28864683
[18]. Chen L, Aleshin AE, Alitongbieke G, Zhou Y, Zhang X, Ye X, Hu M, Ren G, Chen Z, Ma Y, Zhang D, Liu S, Gao W, Cai L, Wu L, Zeng Z, Jiang F, Liu J, Zhou H, Cadwell G, Liddington RC, Su Y, Zhang XK. Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.Nat Commun. 2017 Jul 17;8:16066. PMID:28714476
[19]. Li H, Wang X, Zhang C, Cheng Y, Yu M, Zhao K, Ge W, Cai A, Zhang Y, Han F, Hu Y. HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma. Cancer Lett. 2018 Sep 28;432:121-131. PMID: 29890207
[20]. Lu-Hua Zhang, Yi-Heng Yin, Hong-Zun Chen, Shi-Yu Feng, Jia-Lin Liu, Ling Chen, Wen-Liang Fu, Guo-Chen Sun, Xin-Guang Yu, Dong-Gang Xu. TRIM24 Promotes Stemness and Invasiveness of Glioblastoma Cells via Activating SOX2 Expression. Neuro Oncol. 2020 Jun 3;noaa138. doi: 10.1093/neuonc/noaa138.
[21]. Ke Nie, Jin Li, Xujun He, Yuqing Wang, Qiongya Zhao, Miaomiao Du, Hongwei Sun, Jinjing Wang, Jianxin Lyu, Hezhi Fang, Liqin Jin. COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells. Oncogenesis. 2020 May 15;9(5):51. doi: 10.1038/s41389-020-0231-2. 
[22]. Si-Jing Li, Xiao-Hui Wei, Xiao-Man Zhan, Jin-Yong He, Yu-Qi Zeng, Xue-Mei Tian, Sheng-Tao Yuan, Li Sun.Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner. Cancers (Basel). 2020;12(12):3864. doi: 10.3390/cancers12123864. PMID: 33371368
[23]. Xiaolong Zhang, Qinli Ruan, Yiqian Zhai, Dandan Lu, Chen Li, Yahan Fu, Zihui Zheng, Ying Song, Jun Guo.Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment. Cancer Sci. 2020;111(10):3802-3812. doi: 10.1111/cas.14577.PMID: 32691974 
[24]. Xiaoying Hou, Hongzhi Du, Xingping Quan, Lei Shi, Qianqian Zhang, Yao Wu, Yang Liu, Jing Xiao, Yong Li, Ligong Lu, Xun Ai, Meixiao Zhan, Shengtao Yuan, Li Sun. Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway. Front Pharmacol. 2018;9:21. doi: 10.3389/fphar.2018.00021. PMID: 29472856
[25]. Biao Geng, Jinshun Pan, Ting Zhao, Jie Ji, Chen Zhang, Ying Che, Jing Yang, Hui Shi, Juan Li, Hong Zhou, Xianmin Mu, Che Xu, Chao Wang, Yue Xu, Zheng Liu, Hao Wen, Qiang You.Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer. J Exp Clin Cancer Res. 2018;37(1):208. doi: 10.1186/s13046-018-0876-2.PMID: 30165890